Characterization of A(2A) adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding

British Journal of Pharmacology

Volumn 122, Issue 2, 1997, Pages 386-392

  Varani, Katia ^a   Gessi, Stefania ^a   Dalpiaz, Alessandro ^a   Ongini, Ennio ^b   Borea, Pier Andrea ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b Schering Plough Research Institute   (Italy)

Author keywords

3H SCH 58261 binding; Adenosine A(2A) receptor ligands; Adenosine A(2A) receptors; Cyclic cAMP assays; Human lymphocyte membranes; Thermodynamic analysis

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 7 (2 PHENYLETHYL) 2 (2 FURYL)PYRAZOLO [4,3 E] 1,2,4 [1,5 C] PYRIMIDINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; PYRIMIDINE DERIVATIVE; RADIOLIGAND; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; CYCLIC AMP; TRIAZOLE DERIVATIVE; TRITIUM;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; LYMPHOCYTE MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR AFFINITY; RECEPTOR BINDING; THERMODYNAMICS; BIOSYNTHESIS; BLOOD; CELL MEMBRANE; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; LYMPHOCYTE; METABOLISM;

CELL MEMBRANE; CYCLIC AMP; HUMANS; LYMPHOCYTES; PYRIMIDINES; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; THERMODYNAMICS; TRIAZOLES; TRITIUM;

EID: 0030610508     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701378     Document Type: Article

References (37)

1. AARONS, R.D., NIES, A.S., GAL, J., HEGSTRAND, L.R. & MOLINOFF, P.B. (1980). Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration. J. Clin. Invest., 65, 949-957.
2. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett., 4, 2539-2544.
3. 3H]-SCH 58261 to coronary artery membranes. Circ. Res., 79, 1153-1160.
4. BONNAFOUS, J.C., DORNAND, J., FAVERO, J. & MANI, J.C. (1982). Lymphocyte membrane adenosine receptors coupled to adenylate cyclase properties and occurrence in various lymphocyte subclasses. J. Receptor Res., 2, 347-366.
5. 2A receptor ligands. Biochem. Pharmacol., 49, 461-469.
6. BOYUM, A. (1968). Isolation of mononuclear cells and granulocytes from blood. Scand. J. Clin. Immunol., 21, 77.
7. BRADFORD, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal. Biochem., 72, 248.
8. BROWN, B.L., ALBANO, J.D.M., EKINS, R.I. & SGHERZI, A.M. (1971). A simple and sensitive saturation assay method for the measurement of adenosine 3′:5′-cyclic monophosphate. Biochem. J., 121, 561-562.
9. 2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 335, 64-69.
10. 3H] NECA in rat striatal membranes. Mol. Pharmacol., 29, 331-346.
11. BURT, D.R. (1986). Receptor binding methodology and analysis. In Receptor Binding in Drug Discovery, ed. O'Brien, R.A., pp. 3-30, New York: Marcel Dekker.
12. CARRERA, J.C., SAVEN, A. & PIRO, L.D. (1994). Purine metabolism of lymphocytes. New Drug Therapy, 8, 357-380.
13. 50) of an enzymatic reaction. Biochem. Pharmacol., 22, 3099-3108.
14. 3H]-SCH 58261. J. Pharmacol. Exp. Ther., 298, 726-732.
15. 3H]-SCH 58261. Br. J. Pharmacol., (in press).
16. FINNEY, D.J. (1978). Statistical Methods in Biological Assay. ed. Griffin, G. pp. 80-82. London.
17. FREDHOLM, B.B., ABBRACCHIO, M.P., BURNSTOK, G., DALY, J.W., HARDEN, T.K., JACOBSON, K.A., LEFF, P. & WILLIAMS, M. (1994). Nomenclature and classification of purinoreceptors. Pharmacol. Rev., 46, 143-156.
18. 2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leukocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 262-267.
19. GILLI, P., FERRETTI, V., GILLI, G. & BOREA, P.A. (1994). Enthalpyentropy compensation in drug-receptor binding. J. Phys. Chem., 98, 1515-1518.
20. HUTCHISON, K.A., NERVIS, B., PERINI, F. & FOX, I.H. (1990). Soluble and membrane-associated human low-affinity adenotin binding protein (adenotin): properties and homology with mammalian and avian stress proteins. Biochemistry, 29, 5138-5144.
21. 2 receptors in rat brain. J. Pharmacol. Exp. Ther., 251, 888-893.
22. 2-adenosine receptors using radioligand binding and photoaffinity labeling. J. Receptor Res., 12, 149-169.
23. LINDEN, J., JACOBSON, M.A., HUTCHINS, C. & WILLIAMS, M. (1994). Adenosine receptors. In Handbook of Receptors and Channels, ed. Peroutka, S.J. pp. 29-44. Boca Raton, FL: CRC Press.
24. 3H]-CGS 21680 in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 539-541.
25. MUNSON, P.J. & RODBARD, D. (1980). Ligand: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem., 107, 220-239.
26. 2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis. Mol. Pharmacol., 39, 130-135.
27. 2-adenosine receptor. J. Receptor Res., 13, 961-973.
28. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol., 46, 817-822.
29. NORDSTEDT, C. & FREDHOLM, M.M. (1990). A modification of a protein-binding method for rapid quantification of cAMP in cell culture supernatants and body fluids. Anal. Biochem., 189, 231-234.
30. 2A receptors. Trends Pharmacol. Sci., 17, 364-372.
31. OSHORNK, J.P., PALUMBO, G., BREWER, H.B. & EDELHOCH, H. (1976). The thermodynamics of the self-association of the reduced and carboxymethylated form of Apo A-II from the human high density lipoprotein complex. Biochemistry, 15, 317-320.
32. SCHWABE, U., FEIN, T. & LORENZEN, A. (1993). Pharmacological properties of adenosine receptors and adenosine binding proteins. Drug Der. Res., 29, 220-225.
33. VAN CALKER, D., MULLER, M. & HAMPRECHT, B. (1979). Adcnosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells. J. Neurochem., 33, 999-1005.
34. 3H] CGS 21680 to human platelet membranes. Biochem. Pharmacol., 48, 1658-1661.
35. 3H] CGS 21680 binding. Br. J. Pharmacol., 117, 1693-1701.
36. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther., 276, 398-404.
37. 2A adenosine receptor antagonist, to rat striatal membranes. Br. J. Pharmacol., 117, 1381-1386.